Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM): RESULTS FROM THE EMN02/HO95 PHASE 3 TRIAL
4 března, 2021 5:54 pmAuthor(s): Stefania Oliva, Davine Hofste op Bruinink, Lucie Říhová, et al. Abstract: S 102 Session topic: 13. Myeloma...
EFFICACY BY CYTOGENETIC RISK STATUS FOR DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE OR BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
4 března, 2021 5:51 pmAuthor(s): Jesus San-Miguel, Katja Weisel, Gordon Cook, et al. Abstract: S 101 Session topic: 14. Myeloma and other...
MNOHOPOČETNÝ MYELÓM
4 března, 2021 5:49 pmNa kongrese EHA 2017 bol mnohopočetnému myelómu (MM) venovaný značný priestor v rámci edukačného a satelitných sympózií, vedeckej pracovnej skupiny a taktiež v posterovej sekcii....
QUIZARTINIB (AC220) IN PATIENTS WITH FLT3-ITD(+) RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A RANDOMIZED PHASE 2 STUDY
4 března, 2021 5:37 pmAuthor(s): Nigel Russell, Martin S. Tallman, Stuart Goldberg Abstract: ABSSUB-4757 Session topic: 4. Acute myeloid leukemia – Clinical...
ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO REQUIRE TWO COURSES OF INDUCTION THERAPY TO ACHIEVE COMPLETE REMISSION (CR) SHOULD UNDERGO ALLOGENEIC TRANSPLANT (ALLO-SCT) DURING THE FIRST CR
4 března, 2021 5:32 pmAuthor(s): Hiroaki Shimizu, Hiroshi Handa, Nahoko Hatsumi, et al. Abstract: ABSSUB-4989 Session topic: 4. Acute myeloid leukemia –...
RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
4 března, 2021 5:29 pmAuthor(s): Hervé Dombret, John F. Seymour, Aleksandra Butrym, et al. Abstract: LB-6212 Session topic: 4. Acute myeloid leukemia...
VALIDATION OF EUROPEAN LEUKEMIA NET (ELN) GUIDELINES FOR CYTOGENETICALLY NORMAL AML IN ASSOCIATION WITH NPM1 AND FLT3-ITD MUTATIONS: FURTHER STRATIFICATION FOCUSING ON WT1 EXPRESSION
4 března, 2021 5:26 pmAuthor(s): Jae-Ho Yoon, Hee-Je Kim, Young-Woo Jeon, et al. Abstract: ABSSUB-3999 Session topic: 4. Acute myeloid leukemia –...
AKUTNÍ MYELOIDNÍ LEUKEMIE – NOVINKY Z KONFERENCE EVROPSKÉ HEMATOLOGICKÉ SPOLEČNOSTI
4 března, 2021 5:08 pmKonference EHA se věnovala extenzivně oblasti preleukemických predispozičních stavů a dále vlivu stárnutí na vznik a léčebné možnosti akutní myeloidní leukemie (AML). V oblastech...
SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
4 března, 2021 4:58 pmAuthor(s): James Bussel, Michael Tarantino, Victor Blanchette, et al. Abstract: P727 Session topic: 32. Platelets disorders Background:...
TREATMENT OF PRIMARY ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) WITH FOSTAMATINIB, AN ORAL SYK INHIBITOR: RESULTS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES
4 března, 2021 4:48 pmAuthor(s): J Bussel, J Mayer, L Cervinek, K Chojnowski, et al. Abstract: S435 Session topic: 32. Platelets disorders...